Deep PSA response and extended time‐to‐nadir as robust predictors of survival in Asian patients with de novo metastatic hormone‐sensitive prostate cancer receiving upfront intensified treatment
Our analysis demonstrates that alternative PSA targets can predict treatment response and survival outcomes in de novo mHSPC patients in a real-world setting, providing valuable information for patient counselling and potentially guiding future trial design.
Authors
- Cheuk Y. Tang (ORCID: https://orcid.org/0000-0002-9828-0092)
- Chi‐Ho Leung (ORCID: https://orcid.org/0000-0001-5484-9390)
- H. Mok
- Jeremy Yuen‐Chun Teoh (ORCID: https://orcid.org/0000-0002-9361-2342)
- Chi‐Fai Ng (ORCID: https://orcid.org/0000-0002-1723-9646)
- David Leung (ORCID: https://orcid.org/0000-0002-2078-7934)
- Chris H.‐M. Wong
- Ivan Ching‐Ho Ko (ORCID: https://orcid.org/0000-0003-1682-1420)
- Chun‐F. B. Kwok
- Cheuk‐K. K. Cheng
- Brian Siu (ORCID: https://orcid.org/0009-0000-7974-6371)
- Yung‐Y. J. Lim
- Peter K.‐F. Chiu
Institutions
- Chinese University of Hong Kong (HK)
- Medical University of Vienna (AT)
Publication Details
- Journal
- The Prostate
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1002/pros.24797
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.84